View Section: Price ratios
Caprolactam Statements
50
Caprolactam Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
2023-09-30
%
40.326
100
3.515
4.6
36.811
95.4
—
0
1.796
4.3
32.324
92.5
4.487
2.9
-2.631
-6.4
1.465
-0.01
3.321
-3.5
0.89
-0.7
2.431
-2.8
0.53
4.634
2023-03-31
%
45.897
100
2.898
7.3
42.999
92.7
—
0
1.905
4.5
32.099
78
10.9
14.7
-2.989
-7
-0.036
-0.3
7.875
7.5
-1.153
-0.08
9.028
7.6
1.963
4.6
View Section: Balance Sheet